Chronic hypertension in pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 23, Issue 2, 2011, Pages 76-81

  Czeizel, Andrew E ^a   Bánhidy, Ferenc ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

chronic hypertension; congenital abnormalities; pregnancy; pregnancy complications; related drug treatment

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOTEROL; FOLIC ACID; HYDRALAZINE; MAGNESIUM SULFATE; METHYLDOPA; METOPROLOL; MULTIVITAMIN; NIFEDIPINE; PRAZOSIN; TERBUTALINE; VERAPAMIL;

ALCOHOL CONSUMPTION; ANEMIA; ANTEPARTUM HEMORRHAGE; ARTICLE; BODY POSTURE; CHRONIC DISEASE; CLINICAL FEATURE; CONGENITAL DISORDER; CONGENITAL MALFORMATION; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ESOPHAGUS ATRESIA; ESOPHAGUS STENOSIS; EXERCISE; FETOTOXICITY; GENETIC PREDISPOSITION; HEART ARRHYTHMIA; HIGH RISK PREGNANCY; HUMAN; HYPOSPADIAS; IMMINENT ABORTION; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; KIDNEY INJURY; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MATERNAL SMOKING; MIGRAINE; NAUSEA AND VOMITING; OLIGOHYDRAMNIOS; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RISK; SIDE EFFECT; SODIUM RESTRICTION; SOLUTIO PLACENTAE; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; WEIGHT CONTROL;

ABNORMALITIES, DRUG-INDUCED; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREMATURE BIRTH; RISK FACTORS;

EID: 79953164310     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e328342b7a9     Document Type: Article

References (32)

1. Rashidi A, Rachman M, Wright JT. Diagnosis and treatment of hypertension. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P, editors. Hurst's the heart, 12th ed. New York: McGraw Hill Medical; 2008. pp. 1610-1629.
2. Pickering TG, Ogedegbe G. Epidemiology of hypertension. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P, editors. Hurst's the heart, 12th ed. New York: McGraw Hill Medical; 2008. pp. 1551-1569.
3. Hall JE, Granger JP, Hall ME, Jones DW. Pathophysiology of hypertension. In: Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P, editors. Hurst's the heart, 12th ed. New York: McGraw Hill Medical; 2008. pp. 1570-1609.
4. Rey E, LeLorier J, Burgess E, et al. Report of the Canadian Hypertension Society Consensus Conference. 3. Pharmacologic treatment of hypertensive treatment in pregnancy. Can Med Assoc J 1997;157:1245-1254.
5. Churchill D. The new American guidelines on the hypertensive disorders of pregnancy. J Hum Hypertens 2001;15:583-585. (Pubitemid 32904122)
6. Gifford R, August P, Cunningham G, et al. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-S15.
7. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572. (Pubitemid 37430158)
8. Banhidy F, Acs N, Puho HE, Czeizel AE. The efficacy of antihypertensive treatment in pregnant women with chronic and gestational hypertension: a population-based study. Hypertens Res 2010;33:460-466. This first population-based case-control study evaluated pregnancy complications and birth outcomes of pregnant women with chronic and gestational hypertension, and estimated the efficacy of antihypertensive drug treatments for the reduction of pregnancy-related risk of chronic hypertension.
9. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R, Iams JD, editors. Maternal-Fetal medicine. Principles and practice, 5th ed. Philadelphia: Saunders; 2004. pp. 859-899.
10. Shepard TH, Lemire RJ. Catalog of teratogenic agents. 11th ed. Baltimore, London: The Johns Hopkins University Press; 2004.
11. Czeizel AE, Rockenbauer M, Siffel CS, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 2001;63:176-185. (Pubitemid 32417246)
12. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997;55:299-305. (Pubitemid 27389919)
13. Ounsted M, Cockburn J, Moar VA, Redman CW. Maternal hypertension with superimposed preeclampsia: Effects on child development at 712 years. Br J Obstet Gynecol 1983;90:644-650.
14. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2005.
15. Sorensen HT, Czeizel AE, Rockenbauer M, et al. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynaecol Scand 2001;80:379-401.
16. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128-135.
17. Cooper WD, Hernandez-Diaz S, Arbogast PQ, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-2451. (Pubitemid 43855047)
18. Lambot MA, Vermeylen D, Noel JC. Angiotensin-II-receptor inhibitors in pregnancy. Lancet 2001;357:1619-1620.
19. Martinovic J, Benachi A, Laurent N, et al. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 2001;358:241-242. (Pubitemid 32718555)
20. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994;171:410-415.
21. Tervila L, Goecke C, Timonen S. Estimation of gestosis of pregnancy (EPH-gestosis). Acta Obstet Gynaecol Scand 1973;52:235-241.
22. Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982;100:265-271. (Pubitemid 12165841)
23. Caton AR, Bell EM, Druschel CM, et al. Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A 2008;82:34-40. This population-based case-control study based of the self-reported high blood pressure and prenatal exposure to antihypertensive drugs in 758 male infants showed a higher risk of severe hypospadias. (Pubitemid 351157088)
24. Pazonyi I, Bod M, Czeizel AE. Postural association. Acta Paediatr Acad Sci Hung 1983;23:431-445.
25. Szendrey T, Danyi G, Czeizel AE. Etiological study on isolated esophageal atresia. Hum Genet 1985;70:51-58. (Pubitemid 15098266)
26. Felix JF, de Jong EM, Torfs CP, et al. Genetic and environmental factors in the etiology of esophageal atresia and/or tracheoesophageal fistula: an overview of the current concepts. Birth Defects Res A 2009;85:111-116.
27. Wong-Gibbons DL, Romitti PA, Sun L, et al. Maternal periconceptional exposure to cigarette smoking and alcohol and esophageal atresia m ±tracheoesophageal fistula. Birth Defects Res A 2008;82:776-784.
28. Oddsberg J, Jia C, Nilsson E, et al. Maternal tobacco smoking, obesity, and low socioeconomic status during early pregnancy in the etiology of esophageal atresia. J Pediatr Surg 2008;43:1791-1795.
29. Baker DJP. Mothers, babies, and disease in later life. London: BMJ Publishing Groups; 1994.
30. Jamerson K, Weber MA, Bakris GL, et al., for the ACCOMPLISH trial investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-2428.
31. Mancia G, De Backer G, Dominiczak A. Guideline for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536.
32. Chobanian AV. Does it matter how hypertension is controlled? N Engl J Med 2008;359:2485-2488.